BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
4420932
Number of visits today
1162
Number of downloads
4057373
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Martini DJ, Jansen CS, Harik LR, Evans ST, Olsen TA, Master VA, Kissick HT, Bilen MA. Case Report: Exceptional Response to Nivolumab Plus Ipilimumab in a Young Woman With TFE3-SFPQ Fusion Translocation-Associated Renal Cell Carcinoma. Front Oncol 2021;11. [DOI: 10.3389/fonc.2021.793808] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Bai Y, Wang X, Liu Y, Ji H, Liu Z, Sun J, Zhang H. Pembrolizumab combined with Axitinib in ASPSCR1-TFE3 gene fusion translocation renal cell carcinoma: a case report and literature review.. [DOI: 10.21203/rs.3.rs-2101971/v1] [Reference Citation Analysis]
2 Ipilimumab/nivolumab. Reactions Weekly 2022;1891:173-173. [DOI: 10.1007/s40278-022-09425-6] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345